+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 220 Pages
  • Global
From
Encephalitis Treatment - Global Strategic Business Report - Product Thumbnail Image

Encephalitis Treatment - Global Strategic Business Report

  • Report
  • April 2026
  • 478 Pages
  • Global
From
From
Pharmaceutical Drug Delivery Market Report 2026 - Product Thumbnail Image

Pharmaceutical Drug Delivery Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Oral Proteins & Peptides Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oral Proteins & Peptides Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
From
From
Growth Factors Market - Global Forecast 2026-2030 - Product Thumbnail Image

Growth Factors Market - Global Forecast 2026-2030

  • Report
  • January 2026
  • 198 Pages
  • Global
From
Acute Kidney Injury Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Acute Kidney Injury Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Menopause Market Report 2023-2033 - Product Thumbnail Image

Menopause Market Report 2023-2033

  • Report
  • May 2023
  • 253 Pages
  • Global
From
From
From
From
From
From
Loading Indicator